论文部分内容阅读
目的探讨妊娠期肝内胆汁淤积症(ICP)的临床干预对围生儿预后的影响。方法将148例ICP患者分为治疗组45例,未治组103例,分析比较治疗组干预治疗后生化指标变化,及治疗组与未治组的围生儿结局。结果治疗组治疗后症状明显改善,血清胆汁酸(TBA)、谷丙转氨酶(ALT)、谷草转氨酶(AST)较治疗前明显下降(P<0.01)。与未治组比较治疗组胎儿窘迫、羊水粪染、新生儿窒息、围生儿死亡,产后出血的发生率均降低(P<0.01)。结论重视妊娠期肝内胆汁淤积症,加强产前检查,及早诊断、治疗,放宽剖宫产指征,对降低围生儿病率具有重要意义。
Objective To investigate the clinical effect of intrahepatic cholestasis of pregnancy (ICP) on the prognosis of perinatal infants. Methods A total of 148 patients with ICP were divided into treatment group (45 cases) and control group (103 cases). The changes of biochemical indexes in the treatment group after treatment were compared with those in the control group and the control group. Results After treatment, the symptoms in the treatment group were significantly improved. The levels of serum bile acid (TBA), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were significantly lower than those before treatment (P <0.01). The incidences of fetal distress, meconium-stained amniotic fluid, neonatal asphyxia, perinatal death and postpartum hemorrhage in treatment group were lower than those in control group (P <0.01). Conclusion Emphasis on intrahepatic cholestasis of pregnancy, to strengthen the prenatal examination, early diagnosis and treatment, to relax indications for cesarean section, to reduce the incidence of perinatal disease is of great significance.